MedTrace Logo

LoViReT (Low Viral Reservoir Treated Patients)

NCT02972931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

The main purpose of this study is to unravel the mechanisms by which the "Low Viral Reservoir Treated" patients (LoViReT) maintain extremely low HIV-1 DNA levels despite having initiated cART during chronic HIV-1 infection. This group may have specific and different clinical, virological and immunogenetical characteristics, compared to patients with regular reservoir size, which might be useful to design new and more effective treatment approaches.

Conditions

Sponsors & Collaborators

  • IrsiCaixa

    lead OTHER

Principal Investigators

  • Javier Martinez-Picado, PhD · IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-18
Primary Completion
2019-06-20
Completion
2019-06-20

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02972931 on ClinicalTrials.gov